Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1999 Jul;8(7):1455–1462. doi: 10.1110/ps.8.7.1455

X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.

A G Pavlovsky 1, M G Williams 1, Q Z Ye 1, D F Ortwine 1, C F Purchase 2nd 1, A D White 1, V Dhanaraj 1, B D Roth 1, L L Johnson 1, D Hupe 1, C Humblet 1, T L Blundell 1
PMCID: PMC2144373  PMID: 10422833

Abstract

Effective inhibitors of matrix metalloproteinases (MMPs), a family of connective tissue-degrading enzymes, could be useful for the treatment of diseases such as cancer, multiple sclerosis, and arthritis. Many of the known MMP inhibitors are derived from peptide substrates, with high potency in vitro but little selectivity among MMPs and poor bioavailability. We have discovered nonpeptidic MMP inhibitors with improved properties, and report here the crystal structures of human stromelysin-1 catalytic domain (SCD) complexed with four of these inhibitors. The structures were determined and refined at resolutions ranging from 1.64 to 2.0 A. Each inhibitor binds in the active site of SCD such that a bulky diphenyl piperidine moiety penetrates a deep, predominantly hydrophobic S'1 pocket. The active site structure of the SCD is similar in all four inhibitor complexes, but differs substantially from the peptide hydroxamate complex, which has a smaller side chain bound in the S'1 pocket. The largest differences occur in the loop forming the "top" of this pocket. The occupation of these nonpeptidic inhibitors in the S'1 pocket provides a structural basis to explain their selectivity among MMPs. An analysis of the unique binding mode predicts structural modifications to design improved MMP inhibitors.

Full Text

The Full Text of this article is available as a PDF (2.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker J. W., Marcy A. I., Rokosz L. L., Axel M. G., Burbaum J. J., Fitzgerald P. M., Cameron P. M., Esser C. K., Hagmann W. K., Hermes J. D. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci. 1995 Oct;4(10):1966–1976. doi: 10.1002/pro.5560041002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein F. C., Koetzle T. F., Williams G. J., Meyer E. F., Jr, Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol. 1977 May 25;112(3):535–542. doi: 10.1016/s0022-2836(77)80200-3. [DOI] [PubMed] [Google Scholar]
  3. Borkakoti N., Winkler F. K., Williams D. H., D'Arcy A., Broadhurst M. J., Brown P. A., Johnson W. H., Murray E. J. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nat Struct Biol. 1994 Feb;1(2):106–110. doi: 10.1038/nsb0294-106. [DOI] [PubMed] [Google Scholar]
  4. Browner M. F., Smith W. W., Castelhano A. L. Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry. 1995 May 23;34(20):6602–6610. doi: 10.1021/bi00020a004. [DOI] [PubMed] [Google Scholar]
  5. Dhanaraj V., Ye Q. Z., Johnson L. L., Hupe D. J., Ortwine D. F., Dunbar J. B., Jr, Rubin J. R., Pavlovsky A., Humblet C., Blundell T. L. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure. 1996 Apr 15;4(4):375–386. doi: 10.1016/s0969-2126(96)00043-3. [DOI] [PubMed] [Google Scholar]
  6. Finzel B. C., Baldwin E. T., Bryant G. L., Jr, Hess G. F., Wilks J. W., Trepod C. M., Mott J. E., Marshall V. P., Petzold G. L., Poorman R. A. Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity. Protein Sci. 1998 Oct;7(10):2118–2126. doi: 10.1002/pro.5560071008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lovejoy B., Cleasby A., Hassell A. M., Longley K., Luther M. A., Weigl D., McGeehan G., McElroy A. B., Drewry D., Lambert M. H. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science. 1994 Jan 21;263(5145):375–377. doi: 10.1126/science.8278810. [DOI] [PubMed] [Google Scholar]
  8. Lovejoy B., Hassell A. M., Luther M. A., Weigl D., Jordan S. R. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry. 1994 Jul 12;33(27):8207–8217. doi: 10.1021/bi00193a006. [DOI] [PubMed] [Google Scholar]
  9. McPhalen C. A., Schnebli H. P., James M. N. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg. FEBS Lett. 1985 Aug 19;188(1):55–58. doi: 10.1016/0014-5793(85)80873-5. [DOI] [PubMed] [Google Scholar]
  10. Stams T., Spurlino J. C., Smith D. L., Wahl R. C., Ho T. F., Qoronfleh M. W., Banks T. M., Rubin B. Structure of human neutrophil collagenase reveals large S1' specificity pocket. Nat Struct Biol. 1994 Feb;1(2):119–123. doi: 10.1038/nsb0294-119. [DOI] [PubMed] [Google Scholar]
  11. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 1996 May 3;85(3):299–302. doi: 10.1016/s0092-8674(00)81107-1. [DOI] [PubMed] [Google Scholar]
  12. Stetler-Stevenson W. G., Hewitt R., Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol. 1996 Jun;7(3):147–154. doi: 10.1006/scbi.1996.0020. [DOI] [PubMed] [Google Scholar]
  13. Van Doren S. R., Kurochkin A. V., Hu W., Ye Q. Z., Johnson L. L., Hupe D. J., Zuiderweg E. R. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. Protein Sci. 1995 Dec;4(12):2487–2498. doi: 10.1002/pro.5560041205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Woessner J. F., Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991 May;5(8):2145–2154. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES